| Intermediates

> PRODUCT PROFILE > Dapoxetine HCL Intermediates

Bulk APIS

Commercialized Products

Products Under Commercialization

Products Under Pipeline

Intermediates

Carvedilol Intermediates

Citalopram / Escitalopram intermediates

Duloxetine intermediates

Ondansetron Hydrochloride Dihydrate

Rivastigmine intermediates

Ziprasidone Intermediates

Bilastine Intermediates

Carteolol Intermediates

Cilastazole Intermediates

Dapoxetine HCl Intermediates

Darifenacin intermediates

D- Serine Derivatives

L Valine Derivatives

L Proline Derivatives

L Alanine Derivatives

Lacosamide Intermediates

Lidocaine intermediate

Nebivolol Intermediates

Racecadotril Intermediates

RaloxefineHCl Intermediates

Ranolazine intermediates

Repaglinide Intermediates

Rotigotine intermediates

Silodosin Intermediates

Sitagliptin intermediates

Sofosbuvir intermediates

Tartaric Acid Derivatives

Tolterodine Tartrate Intermediates

Valsartan intermediates

Vildagliptin intermediates

Others products

Products under consideration

Abiraterone Acetate

Bazedoxifene Acetate

Dimethyl Fumarate

Fingolimod hydrochloride

Lurasidone hydrochloride

Memantine hydrochloride

Paliperidone Palmitate

Dapoxetine Hydrochloride (CAS Number : 129938-20-1)

3-Chloro-1-phenylpropan-1-one (CAS No: 936-59-4).
3-Chloro-1-phenylpropan-1-ol (CAS No: 18776-12-0).
Racemic Dapoxetine Oxalate
Racemic Dapoxetine Hydrochloride (CAS No: 1071929-03-7).
Dapoxetine Base (CAS No: 119356-77-3).
3-Amino-3-phenylpropanoic acid (CAS No: 614-19-7).